-
1
-
-
0016753740
-
Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions
-
Chang R, Deen W, Robertson C, Brenner B: Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int 8: 212-218, 1975
-
(1975)
Kidney Int
, vol.8
, pp. 212-218
-
-
Chang, R.1
Deen, W.2
Robertson, C.3
Brenner, B.4
-
2
-
-
0017838170
-
Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations
-
Bohrer M, Baylis C, Humes H, Glassock R, Robertson C, Brenner B: Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. J Clin Invest 61: 72-78, 1978
-
(1978)
J Clin Invest
, vol.61
, pp. 72-78
-
-
Bohrer, M.1
Baylis, C.2
Humes, H.3
Glassock, R.4
Robertson, C.5
Brenner, B.6
-
3
-
-
0018147284
-
Glomerular filtration of proteins: Clearance of anionic, neutral and cationic horseradish peroxidase in the rat
-
Rennke H, Patel Y, Venkatachalam M: Glomerular filtration of proteins: Clearance of anionic, neutral and cationic horseradish peroxidase in the rat. Kidney Int 13: 278-288, 1978
-
(1978)
Kidney Int
, vol.13
, pp. 278-288
-
-
Rennke, H.1
Patel, Y.2
Venkatachalam, M.3
-
4
-
-
0016716868
-
Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins
-
Rennke H, Cotran R, Venkatachalam M: Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol 67: 638-646, 1975
-
(1975)
J Cell Biol
, vol.67
, pp. 638-646
-
-
Rennke, H.1
Cotran, R.2
Venkatachalam, M.3
-
5
-
-
0017359587
-
Glomerular permeability: In vivo tracer studies with polyanionic and polycationic ferritins
-
Rennke H, Venkatachalam M: Glomerular permeability: In vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int 11: 44-53, 1977
-
(1977)
Kidney Int
, vol.11
, pp. 44-53
-
-
Rennke, H.1
Venkatachalam, M.2
-
6
-
-
0029013068
-
Charge selectivity in kidney ultrafiltration
-
Comper W, Glascow E: Charge selectivity in kidney ultrafiltration. Kidney Int 47: 1242-1251, 1995
-
(1995)
Kidney Int
, vol.47
, pp. 1242-1251
-
-
Comper, W.1
Glascow, E.2
-
7
-
-
0021262325
-
Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell
-
Kerjaschki D, Sharkey D, Farquhar M: Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98:1591-1596, 1984
-
(1984)
J Cell Biol
, vol.98
, pp. 1591-1596
-
-
Kerjaschki, D.1
Sharkey, D.2
Farquhar, M.3
-
8
-
-
0035796487
-
Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin
-
Doyonnas R, Kershaw D, Duhme C, Merkens H, Chelliah S, Graf T, McNagny K: Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 194: 13-27, 2001
-
(2001)
J Exp Med
, vol.194
, pp. 13-27
-
-
Doyonnas, R.1
Kershaw, D.2
Duhme, C.3
Merkens, H.4
Chelliah, S.5
Graf, T.6
McNagny, K.7
-
9
-
-
0019304713
-
Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion
-
Kanwar Y, Linker A, Farquhar M: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 86: 688-693, 1980
-
(1980)
J Cell Biol
, vol.86
, pp. 688-693
-
-
Kanwar, Y.1
Linker, A.2
Farquhar, M.3
-
10
-
-
0019995158
-
Mechanisms of proteinuria in human glomerulonephritis
-
Myers B, Okarma T, Friedman S, Bridges C, Ross J, Asseff S, Deen W: Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest 70: 732-746, 1982
-
(1982)
J Clin Invest
, vol.70
, pp. 732-746
-
-
Myers, B.1
Okarma, T.2
Friedman, S.3
Bridges, C.4
Ross, J.5
Asseff, S.6
Deen, W.7
-
11
-
-
0027362463
-
Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans
-
Guasch A, Deen W, Myers B: Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest 92: 2274-2282, 1993
-
(1993)
J Clin Invest
, vol.92
, pp. 2274-2282
-
-
Guasch, A.1
Deen, W.2
Myers, B.3
-
12
-
-
0019476493
-
Minimal change nephropathy: An electrochemical disorder of the glomerular membrane
-
Carrie B, Salyer W, Myers B: Minimal change nephropathy: An electrochemical disorder of the glomerular membrane. Am J Med 70: 262-268, 1981
-
(1981)
Am J Med
, vol.70
, pp. 262-268
-
-
Carrie, B.1
Salyer, W.2
Myers, B.3
-
13
-
-
0027312478
-
Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular disease
-
Van den Born J, van den Heuvel L, Bakker M, Veerkamp J, Assmann K, Weening J, Berden J: Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular disease. Kidney Int 43: 454-463, 1993
-
(1993)
Kidney Int
, vol.43
, pp. 454-463
-
-
Van den Born, J.1
van den Heuvel, L.2
Bakker, M.3
Veerkamp, J.4
Assmann, K.5
Weening, J.6
Berden, J.7
-
14
-
-
0032815533
-
Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane
-
Groffen A, Veerkamp J, Monnens L, van den Heuvel L: Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane. Nephrol Dial Transplant 14: 2119-2129, 1999
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 2119-2129
-
-
Groffen, A.1
Veerkamp, J.2
Monnens, L.3
van den Heuvel, L.4
-
15
-
-
0028297289
-
Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane
-
Tamsma J, van den Born J, Bruijn J, Assmann K, Weening J, Berden J, Wieslander J, Schrama E, Hermans J, Veerkamp J, Lemkes H, van der Woude F: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320, 1994
-
(1994)
Diabetologia
, vol.37
, pp. 313-320
-
-
Tamsma, J.1
van den Born, J.2
Bruijn, J.3
Assmann, K.4
Weening, J.5
Berden, J.6
Wieslander, J.7
Schrama, E.8
Hermans, J.9
Veerkamp, J.10
Lemkes, H.11
van der Woude, F.12
-
16
-
-
0032842107
-
Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis
-
Raats C, Luca M, Bakker M, van Der Wal A, Heeringa P, van Goor H, van den Born J, de Heer E, Berden J: Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis. J Am Soc Nephrol 10: 1689-1699, 1999
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 1689-1699
-
-
Raats, C.1
Luca, M.2
Bakker, M.3
van Der Wal, A.4
Heeringa, P.5
van Goor, H.6
van den Born, J.7
de Heer, E.8
Berden, J.9
-
17
-
-
0035228861
-
ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy
-
Wapstra F, Navis G, van Goor J, van den Born J, Berden J, de Jong P, de Zeeuw D: ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy. Exp Nephrol 9: 21-27, 2001
-
(2001)
Exp Nephrol
, vol.9
, pp. 21-27
-
-
Wapstra, F.1
Navis, G.2
van Goor, J.3
van den Born, J.4
Berden, J.5
de Jong, P.6
de Zeeuw, D.7
-
18
-
-
33749577192
-
No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy
-
Van den Born J, Pisa B, Bakker M, Celie J, Straatman C, Thomas S, Viberti G, Kjellen L, Berden J: No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy. J Biol Chem 281: 29606-29613, 2006
-
(2006)
J Biol Chem
, vol.281
, pp. 29606-29613
-
-
Van den Born, J.1
Pisa, B.2
Bakker, M.3
Celie, J.4
Straatman, C.5
Thomas, S.6
Viberti, G.7
Kjellen, L.8
Berden, J.9
-
19
-
-
85190640628
-
-
Wijnhoven TJM, Lensen, JFM, Wismans RGP, Lamrani M, Wevers RA, Rops ALWMM, van der Vlag J, Berden JHM, van den Heuvel LPWJ, van Kuppeveit T: In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria. J Am Soc Nephrol 18: 823-832, 2007
-
Wijnhoven TJM, Lensen, JFM, Wismans RGP, Lamrani M, Wevers RA, Rops ALWMM, van der Vlag J, Berden JHM, van den Heuvel LPWJ, van Kuppeveit T: In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria. J Am Soc Nephrol 18: 823-832, 2007
-
-
-
-
20
-
-
0037530611
-
Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes
-
Jeansson M, Haraldsson B: Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 14: 1756-1765, 2003
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1756-1765
-
-
Jeansson, M.1
Haraldsson, B.2
-
21
-
-
33644806727
-
Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier
-
Jeansson M, Haraldsson B: Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 290: F111-F116, 2006
-
(2006)
Am J Physiol Renal Physiol
, vol.290
-
-
Jeansson, M.1
Haraldsson, B.2
-
22
-
-
0037439268
-
Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney
-
Rossi M, Morita H, Sormunen R, Airenne S, Kreivi M, Wang L, Fukai N, Olsen B, Tryggvason K, Soininen R: Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 22: 236-245, 2003
-
(2003)
EMBO J
, vol.22
, pp. 236-245
-
-
Rossi, M.1
Morita, H.2
Sormunen, R.3
Airenne, S.4
Kreivi, M.5
Wang, L.6
Fukai, N.7
Olsen, B.8
Tryggvason, K.9
Soininen, R.10
-
23
-
-
26944476342
-
Heparan sulfate of perlecan is involved in glomerular filtration
-
Morita H, Yoshimura A, Inui K, Ideura T, Watanabe H, Wang L, Soininen R, Tryggvason K: Heparan sulfate of perlecan is involved in glomerular filtration. J Am Soc Nephrol 16: 1703-1710, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1703-1710
-
-
Morita, H.1
Yoshimura, A.2
Inui, K.3
Ideura, T.4
Watanabe, H.5
Wang, L.6
Soininen, R.7
Tryggvason, K.8
-
24
-
-
5744238949
-
Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line
-
Utriainen A, Sormunen R, Kettunen M, Carvalhaes L, Sajanti E, Eklund L, Kaappinen R, Kitten G, Pihlajaniemi T: Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum Mol Genet 13: 2089-2099, 2004
-
(2004)
Hum Mol Genet
, vol.13
, pp. 2089-2099
-
-
Utriainen, A.1
Sormunen, R.2
Kettunen, M.3
Carvalhaes, L.4
Sajanti, E.5
Eklund, L.6
Kaappinen, R.7
Kitten, G.8
Pihlajaniemi, T.9
-
25
-
-
33645384150
-
Podocyte-derived agrin is responsible for glomerular basement membrane anionic charge [Abstract]
-
Harvey S, Burgess R, Miner J: Podocyte-derived agrin is responsible for glomerular basement membrane anionic charge [Abstract]. J Am Soc Nephrol 16: 1A, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
-
-
Harvey, S.1
Burgess, R.2
Miner, J.3
-
26
-
-
10744232455
-
Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior
-
Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, Friedmann Y, Weinstein T, Li J, Lindahl U, Vlodavsky I: Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 18: 252-263, 2004
-
(2004)
FASEB J
, vol.18
, pp. 252-263
-
-
Zcharia, E.1
Metzger, S.2
Chajek-Shaul, T.3
Aingorn, H.4
Elkin, M.5
Friedmann, Y.6
Weinstein, T.7
Li, J.8
Lindahl, U.9
Vlodavsky, I.10
-
27
-
-
33947279633
-
Elimination of heparan sulfate glycosaminoglycans (HS-GAGs) from the glomerular basement membrane (GBM) using Cre-Lox technology has profound effects on podocyte ultrastructure and function [Abstract]
-
Chen S, Holzman L, Yamaguchi Y, Woods A, McCarthy D, McCarthy K: Elimination of heparan sulfate glycosaminoglycans (HS-GAGs) from the glomerular basement membrane (GBM) using Cre-Lox technology has profound effects on podocyte ultrastructure and function [Abstract]. J Am Soc Nephrol 17: 25A, 2006
-
(2006)
J Am Soc Nephrol
, vol.17
-
-
Chen, S.1
Holzman, L.2
Yamaguchi, Y.3
Woods, A.4
McCarthy, D.5
McCarthy, K.6
-
28
-
-
16644385848
-
A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis
-
Levidiotis V, Freeman C, Punler M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden J, Parish C, Power D: A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. J Am Soc Nephrol 15, 2882-2892, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2882-2892
-
-
Levidiotis, V.1
Freeman, C.2
Punler, M.3
Martinello, P.4
Creese, B.5
Ferro, V.6
van der Vlag, J.7
Berden, J.8
Parish, C.9
Power, D.10
-
29
-
-
0346734139
-
Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis
-
Levidiotis V, Freeman C, Tikellis C, Cooper M, Power D: Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. J Am Soc Nephrol 15: 68-78, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 68-78
-
-
Levidiotis, V.1
Freeman, C.2
Tikellis, C.3
Cooper, M.4
Power, D.5
-
30
-
-
0036830896
-
Involvement of human heparanase in the pathogenesis of diabetic nephropathy
-
Katz A, Van-Dijk D, Aingorn H, Erman A, Davies M, Darmon D, Hurvitz H, Vlodavsky I: Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Isr Med Assoc J 4: 996-1002, 2002
-
(2002)
Isr Med Assoc J
, vol.4
, pp. 996-1002
-
-
Katz, A.1
Van-Dijk, D.2
Aingorn, H.3
Erman, A.4
Davies, M.5
Darmon, D.6
Hurvitz, H.7
Vlodavsky, I.8
-
31
-
-
21344458126
-
Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: A potential role in the pathogenesis of proteinuria in diabetic patients
-
Maxhimer J, Somenek M, Rao G, Pesce C, Baldwin Jr D, Gattuso P, Schwartz M, Lewis E, Prinz R, Xu X: Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 54: 2172-2178, 2005
-
(2005)
Diabetes
, vol.54
, pp. 2172-2178
-
-
Maxhimer, J.1
Somenek, M.2
Rao, G.3
Pesce, C.4
Baldwin Jr, D.5
Gattuso, P.6
Schwartz, M.7
Lewis, E.8
Prinz, R.9
Xu, X.10
-
32
-
-
0036014944
-
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type I and type II diabetic patients: The Di.N.A.S. randomized trial
-
Gambaro G, Kinalska I, Oksa A, Pont'uch P, Hertlova M, Olsovsky J, Manitius J, Fedele D, Czekalski S, Perusicova J, Skrha J, Taton J, Greszczak W, Crepaldi G: Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type I and type II diabetic patients: The Di.N.A.S. randomized trial. J Am Soc Nephrol 13: 1615-1625, 2002
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1615-1625
-
-
Gambaro, G.1
Kinalska, I.2
Oksa, A.3
Pont'uch, P.4
Hertlova, M.5
Olsovsky, J.6
Manitius, J.7
Fedele, D.8
Czekalski, S.9
Perusicova, J.10
Skrha, J.11
Taton, J.12
Greszczak, W.13
Crepaldi, G.14
|